Kidney (Neoplasia RCC)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Neoplasia RCC).php on line 2
Kidney (Neoplasia RCC)

LE WE PMID CA

Kidney (Neoplasia RCC)

11012

Niere (Neubildung RCC)

17 N allylamino 17 demethoxygeldanamycin

5T4 Oncotrophoblast glycoprotein

Aids

Arsenic trioxide ttROS

Bone (Metastasis)

CAR coxsackie and adenovirus receptor

Caspase8

CD95 FAS Apo1

Ceramide synthase6

Ceramide

Colon and rectum (Neoplasia)

EIF2AK3 PERK

Everolimus

Fenretinide

Interleukin24 MDA7

JNK

Kidney (Neoplasia RCC)

Neoplasia (Oncolytic virus)

Pazopanib

Prostate (Neoplasia)

Sorafenib

Sphingomyelinase

Temsirolimus

Vaccine (Oncology)

VHL

2011 1	Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery. [20948318] Cancer Biol Ther 10(12): 1290-305 (2011)
2009 2	MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism. [19417161] Mol Cancer Ther 8(5): 1280-91 (2009)
2011 3	A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels. [21119025] Mol Pharmacol 79(3): 368-80 (2011)
2011 4	Recent developments in kidney cancer. [21672483] Can Urol Assoc J 5(3): 195-203 (2011)
2011 5	Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications. [21801687] Can Urol Assoc J 5(4): 274-82 (2011)
2007 6	Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists. [18542780] Can Urol Assoc J 1(2 Suppl): S13-20 (2007)
2007 7	Systemic therapy for patients with advanced, unresectable ormetastatic renal cell carcinoma: moving to guidelines. [18542783] Can Urol Assoc J 1(2 Suppl): S34-40 (2007)
2011 8	Genomic and proteomic approaches to renal cell carcinoma. [20437403] J Nephrol 24(2): 155-64 (2011)
2011 9	Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. [21888643] J Med Case Reports 5(-): 429 (2011)
2009 10	The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy. [19657325] Kidney Int 76(9): 939-45 (2009)
2011 11	Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma. [21931501] Cancer Manag Res 3(-): 273-85 (2011)
2010 12	Everolimus - a new approach in the treatment of renal cell carcinoma. [21188097] Cancer Manag Res 2(-): 61-70 (2010)
2010 13	Renal cell carcinoma bone metastases: clinical advances. [21789128] Ther Adv Med Oncol 2(2): 75-83 (2010)
2011 14	Advanced treatments in non-clear renal cell carcinoma. [21404194] Urol J 8(1): 1-11 (2011)
2011 15	Tyrosine kinase inhibitors in the treatment of advanced renal cell carcinoma: focus on pazopanib. [22084622] Clin Med Insights Oncol 5(-): 333-42 (2011)
2009 16	VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy. [19216840] Curr Oncol Rep 11(2): 94-101 (2009)
2011 17	Saudi Oncology Society clinical management guidelines for renal cell carcinoma. [21673849] Urol Ann 3 Suppl(-): S3-5 (2011)
2011 18	Biology of metastatic renal cell carcinoma. [21850209] J Cancer 2(-): 369-73 (2011)
2009 19	The clinical implications of the genetics of renal cell carcinoma. [19285230] Urol Oncol 27(2): 131-6 (2009)
2008 20	Human immunodeficiency virus--associated renal cell carcinoma: a transatlantic case series. [18824430] Clin Genitourin Cancer 6(2): 86-90 (2008)
2007 21	Interleukin 2 for patients with renal cancer. [17728709] Nat Clin Pract Oncol 4(9): 497 (2007)
2011 22	Vasculogenic mimicry and mosaic vessels and targeted therapy in renal cell carcinoma. [21906459] Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33(4): 462-7 (2011)
2009 23	Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma. [19254383] J Exp Clin Cancer Res 28(-): 30 (2009)
2011 24	An update on TroVax for the treatment of progressive castration-resistant prostate cancer. [21691576] Onco Targets Ther 4(-): 33-41 (2011)
2010 25	Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers. [21078774] Mol Cancer Ther 9(12): 3115-25 (2010)
2011 26	Molecular aspects of renal cell carcinoma: a review. [21969126] Am J Cancer Res 1(2): 240-254 (2011)
2010 27	Pazopanib in renal cell carcinoma. [21059813] Clin Cancer Res 16(24): 5923-7 (2010)
2010 28	Renal cell carcinoma: focus on safety and efficacy of temsirolimus. [21234295] Clin Med Insights Oncol 4(): 143-54 (2010)
2010 29	Genetic and epigenetic alterations during renal carcinogenesis. [21228928] Int J Clin Exp Pathol 4(1): 58-73 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Neoplasia RCC).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Neoplasia RCC).php on line 92